MAPK3 and familial pancreatic carcinoma: Studies have shown that ADRB2 can directly interact with and upregulate AKR1B1 in pancreatic cancer cells, promoting cell proliferation and inhibiting apoptosis through the ERK1/2 pathway (Xiao et al., 2018).